Inhibition of intestinal tone, motility and prostaglandin biosynthesis by 5,8,11,14-eicosatetraynoic acid (TYA).
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002855:Chromatography, Thin Layer; D003864:Depression, Chemical; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology*; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects* / Q000201:enzymology; D008784:Methysergide / Q000494:pharmacology; D009097:Multienzyme Complexes / Q000378:metabolism; D009119:Muscle Contraction / Q000187:drug effects; D009129:Muscle Tonus / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D010105:Oxygenases / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis*; D013268:Stimulation, Chemical; D014309:Tripelennamine / Q000494:pharmacology
D005231:Fatty Acids, Unsaturated; D009097:Multienzyme Complexes; D011453:Prostaglandins; D014309:Tripelennamine; D001285:Atropine; D010105:Oxygenases; D008784:Methysergide